TD8-32281-83168 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-26
Registered in v-safe
2021-05-26
Dose 1 — Janssen/Johnson & Johnson
2021-05-26
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-05-27
Survey response — days 1–6 daily, dose 1
MedDRA: Dry eye, Eye irritation — Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Burning and dry eyes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-28
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-05-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-06-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-26	Janssen/Johnson & Johnson

Free text

Release 8 — days 1–6 daily, dose 1

2021-05-27

Systemic reaction (other): Burning and dry eyes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dry eye	✓	✓	✓
SRO	Eye irritation	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release